French study explores genome screening for newborns
NCT ID NCT06875089
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study aims to see if it is feasible and acceptable to use genome sequencing to screen newborns for rare diseases in France. Researchers will offer the test to parents of 2,500 newborns across five hospitals, targeting treatable and actionable genetic conditions. The study will also explore why some parents decline and the emotional impact on families who receive results.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could pave the way for routine genome-based newborn screening in France, enabling early detection and management of rare diseases.
What could go wrong
This is a small pilot study (2,500 newborns) focused on feasibility, not on proving health benefits. It may not show clear clinical utility or be accepted by all families.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEWBORN SCREENING PROGRAMMES FOR RARE DISEASES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Besançon
NOT_YET_RECRUITINGBesançon, 25000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Dijon Bourgogne
RECRUITINGDijon, 21000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Hôtel Dieu
NOT_YET_RECRUITINGNantes, 44093, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Rennes - Hôpital Sud
NOT_YET_RECRUITINGRennes, 35203, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU d'Angers
NOT_YET_RECRUITINGAngers, 49933, France
Contact Phone: •••-•••-•••• Email: •••••@•••••